World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 13 June 2016
Main ID:  NCT02791282
Date of registration: 01/06/2016
Prospective Registration: No
Primary sponsor: Hannover Medical School
Public title: CTEPH DIAGNOSIS Europe - MRI
Scientific title: CHANGE-MRI (CTEPH DIAGNOSIS Europe - MRI)
Date of first enrolment: May 2016
Target sample size: 1080
Recruitment status: Recruiting
URL:  https://clinicaltrials.gov/show/NCT02791282
Study type:  Interventional
Study design:  Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic  
Phase:  Phase 3
Countries of recruitment
Germany
Contacts
Name:     Jens Vogel-Claussen, MD
Address: 
Telephone:
Email:
Affiliation:  Hannover Medical School
Name:     Jens Vogel-Claussen, MD
Address: 
Telephone: +49 5115323421
Email: vogel-claussen.jens@mh-hannover.de
Affiliation: 
Name:     Jens Vogel-Claussen, MD
Address: 
Telephone: +49 511 5323421
Email: vogel-claussen.jens@mh-hannover.de
Affiliation: 
Key inclusion & exclusion criteria

Inclusion Criteria:

- Transthoracic echocardiography indicates pulmonary hypertension

- Patients with clinical suspicion for CTEPH, scheduled for SPECT

- Provided informed consent for the study

- Age >18y

Exclusion Criteria:

- Patient unable to undergo MRI (e.g. due to claustrophobia, cardiac pacemaker,
hypersensitivity to MR i.v. contrast imaging agents)

- Women who are pregnant or breast feeding



Age minimum: 18 Years
Age maximum: N/A
Gender: Both
Health Condition(s) or Problem(s) studied
Pulmonary Hypertension
Intervention(s)
Other: Index test: functional dynamic contrast enhanced (DCE)-MRI
Primary Outcome(s)
The proportion of patients with positive MRI in the group of patients with negative VQ-SPECT who are negative in the gold standard [Time Frame: 6 months]
The proportion of patients with positive MRI in the group of patients who have a positive VQ-SPECT diagnosis for chronic pulmonary embolism and who are positive in the gold standard [Time Frame: 6 months]
Secondary Outcome(s)
Secondary ID(s)
CHANGE-MRI
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
University of Sheffield
Heidelberg University
Ludwig-Maximilians - University of Munich
University of Giessen
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history